One Genetic Change Shifted Two THC Tolerance Outcomes in Opposite Directions

Deleting beta-arrestin2 reduced tolerance to one THC effect while increasing tolerance to another in mice. The experiment shows why tolerance cannot always be described as a single change affecting every function equally.

A receptor-regulation experiment

Researchers compared male beta-arrestin2-knockout mice with wild-type littermates after acute and repeated THC. They measured pain-related withdrawal responses, immobility on a ring test and body temperature, alongside cannabinoid-receptor signaling in brain and spinal tissue.

The direction depended on the endpoint

Following repeated THC, knockout mice showed less tolerance to THC’s antinociceptive effect but greater tolerance to catalepsy. Acute catalepsy did not significantly differ by genotype. Both genotypes developed tolerance to hypothermia; the study could not calculate the dose-response potency estimates needed for the same numerical tolerance comparison on that outcome.

Why tissue location matters

Receptor adaptation differed across nervous-system regions. Removing a protein involved in receptor regulation did not prevent every form of desensitization. Some regions instead showed increased adaptation, consistent with overlapping regulatory pathways. Receptor binding, signaling and observable behavior therefore should not be treated as identical measurements.

The translational limit

These findings concern genetically modified mice and experimental THC dosing, not a genetic test that predicts a particular person’s driving or treatment response. No clinical benefit from manipulating beta-arrestin2 was established. For expert interpretation, the paper supports specifying the affected function and comparator; it does not support calling a cannabis user globally tolerant or globally unaffected.

Related analysis: evaluating cannabis tolerance claims.

Primary research

Nguyen PT; Schmid CL; Raehal KM; Selley DE; Bohn LM; Sim-Selley LJ. β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner. Biological psychiatry (2012). DOI: 10.1016/j.biopsych.2011.11.027.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Less Vomiting With CBD Did Not Mean Protection From THC’s Cognitive Effects in Primates

Adding CBD was associated with less first-day vomiting in a small adolescent-primate experiment, but did not prevent the measured THC-related learning disruption. Improvement in one adverse outcome should not be presented as general protection. Three small treatment groups Twelve male squirrel monkeys received vehicle, THC alone or THC with CBD,…

Spread the love

Read Article: Less Vomiting With CBD Did Not Mean Protection From THC’s Cognitive Effects in Primates

A Receptor Mutation Did Not Delay THC Tolerance in a Chemotherapy-Neuropathy Model

A cannabinoid-receptor mutation associated with altered tolerance in other experiments did not delay THC tolerance in mice with cisplatin-related neuropathy. The result shows why a mechanism demonstrated in one pain model may not transfer to another. A chronic pain model with two sexes Researchers studied wild-type mice and animals carrying…

Spread the love

Read Article: A Receptor Mutation Did Not Delay THC Tolerance in a Chemotherapy-Neuropathy Model

Mouse Cannabinoid Withdrawal Findings Depended on Timing and Agonist Efficacy

Behavior after cannabinoid cessation differed with the compound, dose and observation time in a mouse study. An early negative assessment could miss later changes, while a strong response to a synthetic agonist should not be relabeled as a THC result. Continuous observation added information Researchers compared repeated THC with AM2389,…

Spread the love

Read Article: Mouse Cannabinoid Withdrawal Findings Depended on Timing and Agonist Efficacy

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us